IntoCell Revenue

In the year 2025, IntoCell had annual revenue of 2.30B KRW, down -20.86%. IntoCell had revenue of 728.05M in the quarter ending December 31, 2025, with 547.49% growth.

Revenue

2.30B

Revenue Growth

-20.86%

P/S Ratio

256.45

Revenue / Employee

n/a

Employees

n/a

Market Cap

589.61B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.30B	-605.91M	-20.86%
Dec 31, 2024	2.91B	1.29B	79.72%
Dec 31, 2023	1.62B	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	140.03M	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
HansBiomed	100.17B
S.Biomedics	16.55B
Inventage Lab	2.94B
Kangstem Biotech	3.57B
Y-Biologics	2.91B
curacle co.,ltd.	7.10M
NIBEC	32.72B
TiumBio	12.29B

Revenue Rankings